Physician
Leahy-Auer, Joanne
Leahy-Auer, Joanne was paid $248K by Medicaid between Jan 2018 and Dec 2023, across 20 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoLEAHY-AUER, JOANNE
BOURBONNAIS, IL 60914
BOURBONNAIS, IL 60914
33aNPI1548369317assigned 09/21/2006
33bProvider typePediatrics Physician
28Total paid$248K
24GClaims7,508
24DCodes billed20
24AFirst – last monthJan 2018 – Dec 2023
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#489 of 1,805
Median peer was paid$55K
This provider vs. median4.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,421 | $35K | |
| 2019 | 2,069 | $50K | |
| 2020 | 1,171 | $35K | |
| 2021 | 797 | $35K | |
| 2022 | 1,000 | $50K | |
| 2023 | 1,050 | $43K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 2,129 | 1,673 | $93K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 1,379 | 1,008 | $89K |
| 87428 | 5.3% | 216 | 182 | $13K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4.8% | 743 | 596 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.3% | 558 | 450 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.2% | 539 | 400 | $8K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.1% | 102 | 92 | $8K |
| 90686 | 1.3% | 344 | 294 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 343 | 200 | $3K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 36 | 28 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 32 | 31 | $3K |
| 87807 | <1% | 223 | 163 | $2K |
8 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 22 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 76 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 236 | $396.14 |
| 90734 | <1% | 12 | $200.52 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 354 | $198.69 |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | <1% | 56 | $119.49 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 63 | $7.93 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.